Abasaglar

insulin glargine · Eli Lilly Nederland B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Abasaglar, covering 2026-01-21 to 2026-07-13. Get the full timeline:

Most recent: EMA Authorised: Abasaglar (previously Abasria) (insulin glargine) — Eli Lilly Nederland B.V.